Evaluation of utility of antigen-specific IgG antibodies of hypersensitivity pneumonitis.

Evaluation of utility of antigen-specific IgG antibodies of hypersensitivity pneumonitis. - Evaluation of utility of antigen-specific IgG antibodies of hypersensitivity pneumonitis.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000045583

Enrollment

Registered

2021-09-27

Start date

2021-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hypersensitivity pneumonitis

Interventions

Collect the 20ml venous blood for immunological assays.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Criteria for selecting participants: Adult staff member who are walking at Department of Respiratory Medicine, Tokyo Medical and Dental University.

Exclusion criteria

Exclusion criteria: Exclude patients who meet the following criteria: 1)under age 20. 2)Judge as an inappropriate patient by principal investigators.

Design outcomes

Primary

Measure	Time frame
Find the significant difference of the amount of antigen-specific IgG antibodies in serum between disease and control group by ImmunoCAP assays.	—

Countries

Japan

Contacts

Public ContactTsuyoshi Shirai

Tokyo Medical and Dental University Department of Respiratory Medicine

tshipulm@tmd.ac.jp03-5803-5954

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026